The invention herein described relates to an early and specific diagnosis method based on the use of the peptide fragment 75-99 of the URG7 protein. This peptide is used as an antigen to determine the presence of anti-URG7 antibodies in the sera of carrier subjects of the hepatitis virus, of hepatitis B in particular.
Method for diagnosing the risk of preneoplastic and neoplastic liver disease in subjects affected by hepatitis
OSTUNI, Angela;BISACCIA, Faustino
2019-01-01
Abstract
The invention herein described relates to an early and specific diagnosis method based on the use of the peptide fragment 75-99 of the URG7 protein. This peptide is used as an antigen to determine the presence of anti-URG7 antibodies in the sera of carrier subjects of the hepatitis virus, of hepatitis B in particular.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
WO2015197579A1.pdf
non disponibili
Tipologia:
Altro materiale allegato
Licenza:
Dominio pubblico
Dimensione
309.25 kB
Formato
Adobe PDF
|
309.25 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
